Term Sheet: What SaaS Founders Must Read Before Signing

Term Sheet: What SaaS Founders Must Read Before Signing - hero image

Most SaaS founders I work with treat the term sheet as the fin­ish line. They spent six months get­ting an investor to “yes,” the num­ber on the front page is big­ger than they expect­ed, and the instinct is to sign before the offer evap­o­rates. That instinct is exact­ly how founders end up with 25 years of work and noth­ing to show for it. A term sheet is not the fin­ish line. It is the rule­book for every dol­lar that ever comes out of your com­pa­ny, and the val­u­a­tion on page one is usu­al­ly the least impor­tant thing in it.

Here is the part nobody tells first-time CEOs: the val­u­a­tion gets all the atten­tion, but the liq­ui­da­tion pref­er­ence, the par­tic­i­pa­tion rights, and the board con­trol terms decide how much mon­ey you per­son­al­ly walk away with when you sell. I have watched a com­pa­ny raise two hun­dred mil­lion dol­lars, build gen­uine­ly great soft­ware, sell for a real price, and hand the founders zero. Not a small num­ber — zero. The cus­tomers loved the prod­uct. The founders just did not under­stand the math buried in their own term sheets.

This guide walks through what a term sheet actu­al­ly is, the claus­es that mat­ter and the ones that do not, the dif­fer­ence between eco­nom­ic terms and con­trol terms, a worked exam­ple show­ing how the same exit price pro­duces wild­ly dif­fer­ent founder out­comes depend­ing on the term sheet you signed years ear­li­er, and the nego­ti­at­ing moves that actu­al­ly shift terms in your favor. By the end you will know which lines on a term sheet to fight over and which to let go — and why sign­ing the wrong term sheet is a deci­sion you live with for the entire life of the com­pa­ny.

What a Term Sheet Actually Is

A term sheet is a short, most­ly non-bind­ing doc­u­ment — usu­al­ly two to eight pages — that lays out the key terms of a pro­posed invest­ment or acqui­si­tion before the lawyers draft the long-form agree­ments. Think of it as the archi­tec­tur­al blue­print signed off before any­one pours con­crete. It is “non-bind­ing” in the sense that it does not legal­ly force the deal to close, but that fram­ing is mis­lead­ing in prac­tice. Once both sides sign a term sheet, rough­ly 90% of the deal is set­tled. The forty-page Stock Pur­chase Agree­ment that fol­lows is most­ly the lawyers trans­lat­ing the term sheet into enforce­able lan­guage. What­ev­er you con­ced­ed on the term sheet, you almost nev­er claw back lat­er.

The rea­son this mat­ters for a SaaS CEO specif­i­cal­ly is that your com­pa­ny runs on recur­ring rev­enue, which makes it finance­able and acquirable in ways most busi­ness­es are not. You will like­ly see more than one term sheet over the com­pa­ny’s life — a growth equi­ty round, a recap­i­tal­iza­tion, a strate­gic acqui­si­tion offer. Each one is a moment where the terms you accept silent­ly reprice every share you own.

A few bind­ing pieces usu­al­ly do sur­vive even in a “non-bind­ing” term sheet, and you should read them care­ful­ly:

  1. Con­fi­den­tial­i­ty. You can­not dis­close the terms pub­licly. Stan­dard, fine.
  2. No-shop / exclu­siv­i­ty. This is the one that bites. A no-shop clause says that once you sign, you can­not talk to oth­er investors or buy­ers for a set peri­od — often 30 to 60 days. That hands the oth­er side enor­mous lever­age dur­ing dili­gence, because they know you have no alter­na­tive on the table. Nego­ti­ate the no-shop win­dow down, and nev­er sign one before you have run a com­pet­i­tive process.
  3. Expens­es. Who pays legal and dili­gence costs if the deal col­laps­es.

Every­thing else — val­u­a­tion, pref­er­ences, board seats, vest­ing — is eco­nom­i­cal­ly bind­ing in spir­it even when it is tech­ni­cal­ly non-bind­ing on paper.

The Two Kinds of Terms: Economics and Control

Every clause on a term sheet falls into one of two buck­ets, and con­fus­ing them is the most com­mon mis­take I see.

Eco­nom­ic terms deter­mine who gets how much mon­ey, and in what order, when the com­pa­ny is sold or liq­ui­dat­ed. These are val­u­a­tion, liq­ui­da­tion pref­er­ence, par­tic­i­pa­tion, div­i­dends, and anti-dilu­tion. They decide the size of your check at exit.

Con­trol terms deter­mine who gets to make deci­sions. These are board com­po­si­tion, vot­ing rights, pro­tec­tive pro­vi­sions (veto rights), and infor­ma­tion rights. They decide whether you can run the com­pa­ny the way you want — and, crit­i­cal­ly, whether you can even choose to sell when the eco­nom­ics are good for you.

A naive founder opti­mizes the head­line val­u­a­tion and ignores the rest. A sophis­ti­cat­ed one knows that a slight­ly low­er val­u­a­tion with clean eco­nom­ic and con­trol terms is almost always worth more than a high­er val­u­a­tion loaded with pref­er­ences and vetoes. The val­u­a­tion is the num­ber you brag about at din­ner. The oth­er terms are the num­ber that hits your bank account.

Economic Versus Control Terms in a Term Sheet — Two contrasting weighing instruments side by side on a dark

Economic Terms That Decide What You Keep

Valuation: Pre-Money vs Post-Money

The first num­ber on the term sheet is the val­u­a­tion, and you must know which kind it is.

  • Pre-mon­ey val­u­a­tion is what the investor thinks the com­pa­ny is worth before their mon­ey goes in.
  • Post-mon­ey val­u­a­tion is the pre-mon­ey val­ue plus the new invest­ment.

The for­mu­la is sim­ple but the con­se­quences are not:

Post-Mon­ey Val­u­a­tion = Pre-Mon­ey Val­u­a­tion + New Invest­ment

Investor Own­er­ship % = New Invest­ment ÷ Post-Mon­ey Val­u­a­tion

Sup­pose an investor offers a $20M pre-mon­ey val­u­a­tion and wants to put in $5M. The post-mon­ey val­u­a­tion is $25M, and the investor owns $5M ÷ $25M = 20% of the com­pa­ny. But if they quote the same $5M check at a $20M post-mon­ey val­u­a­tion, the pre-mon­ey is only $15M, and they own $5M ÷ $20M = 25%. Same dol­lars, same head­line-ish num­ber, five per­cent­age points of your com­pa­ny gone. Always con­firm in writ­ing whether a quot­ed val­u­a­tion is pre- or post-mon­ey before you cel­e­brate.

Liquidation Preference: The Term That Matters Most

If you read noth­ing else in this arti­cle, read this sec­tion. The liq­ui­da­tion pref­er­ence deter­mines who gets paid first, and how much, when the com­pa­ny is sold. It is the sin­gle most impor­tant eco­nom­ic term, and it is the one founders under­stand least.

A liq­ui­da­tion pref­er­ence says the investor gets their mon­ey back — or some mul­ti­ple of it — before com­mon share­hold­ers (you and your team) see a dol­lar. A “1x liq­ui­da­tion pref­er­ence” means the investor gets 1 times their invest­ment back first. A “2x” means twice their mon­ey before you get any­thing. The mul­ti­ple is the dif­fer­ence between a fair deal and a trap. The indus­try-stan­dard ref­er­ence doc­u­ments that long-form agree­ments are draft­ed from — the Nation­al Ven­ture Cap­i­tal Asso­ci­a­tion mod­el legal doc­u­ments — assume a 1x non-par­tic­i­pat­ing pref­er­ence as the base­line, which is a use­ful bench­mark when an investor pro­pos­es any­thing more aggres­sive.

Here is why it com­pounds: investors usu­al­ly hold pre­ferred stock, and the pref­er­ence attach­es to that pre­ferred stock. The more cap­i­tal you raise across more rounds, the taller the stack of pref­er­ences sit­ting ahead of your com­mon shares becomes. This is the math behind the com­pa­ny that sells for hun­dreds of mil­lions while the founders get noth­ing. The pref­er­ence stack got taller than the exit price.

Simple Preferred vs Participating Preferred

With­in liq­ui­da­tion pref­er­ences, there is a fork that changes your out­come dra­mat­i­cal­ly, and the ter­mi­nol­o­gy is delib­er­ate­ly con­fus­ing. There are two fla­vors:

Sim­ple (non-par­tic­i­pat­ing) pre­ferred is com­pa­ny-friend­ly. There is a dol­lar fig­ure tied to the orig­i­nal check size that the investor is guar­an­teed in a down­side sce­nario. When the com­pa­ny does well, the investor faces a choice: take the pref­er­ence (their mon­ey back), or con­vert to com­mon and take their own­er­ship per­cent­age of the pro­ceeds — whichev­er is greater. They get one or the oth­er, not both.

Par­tic­i­pat­ing pre­ferred is investor-friend­ly and far more dan­ger­ous for you. The investor gets paid their pref­er­ence amount first, and then par­tic­i­pates again, shar­ing in the remain­ing pro­ceeds accord­ing to their own­er­ship per­cent­age. They get their mon­ey back plus their slice of every­thing that is left. This is some­times called “dou­ble dip­ping,” and that nick­name is accu­rate.

The table makes the dif­fer­ence con­crete. Assume an investor put in $5M for 25% own­er­ship with a 1x pref­er­ence, and the com­pa­ny sells for $40M:

TermWhat the investor takesWhat's left for everyone else
Simple (non-participating) 1xGreater of $5M preference or 25% of $40M = greater of $5M or $10M = $10M$30M
Participating 1x$5M preference plus 25% of remaining $35M = $5M + $8.75M = $13.75M$26.25M

Same check, same own­er­ship, same exit price. Par­tic­i­pa­tion costs the com­mon share­hold­ers $3.75M on a $40M exit. On larg­er rais­es with mul­ti­ple par­tic­i­pat­ing rounds stacked on top of each oth­er, the gap is enor­mous. Fight hard for sim­ple, non-par­tic­i­pat­ing pre­ferred. If you must accept par­tic­i­pa­tion, nego­ti­ate a cap on it — for exam­ple, par­tic­i­pa­tion that stops once the investor has made 3x their mon­ey.

Dividends and the Hidden Compounding Cost

Some term sheets include a div­i­dend on the pre­ferred stock — often quot­ed as a per­cent­age like 8% per year. If the div­i­dend is cumu­la­tive, it accrues and com­pounds whether or not the com­pa­ny ever pays it in cash, and the accrued amount gets added to the liq­ui­da­tion pref­er­ence. An 8% cumu­la­tive div­i­dend on a $5M check is rough­ly 1.47x the orig­i­nal check after five years — mean­ing the investor is owed about $7.35M before you see any­thing, not $5M. It looks small on the term sheet. It is not small at exit.

This is the same mech­a­nism that played out when War­ren Buf­fett invest­ed in Gold­man Sachs dur­ing the 2008 finan­cial cri­sis. He took pre­ferred stock with a 10% coupon, which paid him rough­ly $500M a year no mat­ter what hap­pened to the busi­ness, plus own­er­ship upside. The peo­ple run­ning the com­pa­ny hat­ed the deal and could not wait to buy him out — because the coupon was qui­et­ly drain­ing the firm every year. A div­i­dend on your pre­ferred stock works exact­ly the same way against you.

Anti-Dilution Provisions: The Clause That Fires When You’re Down

Anti-dilu­tion pro­vi­sions pro­tect the investor’s own­er­ship per­cent­age if you lat­er raise mon­ey at a low­er val­u­a­tion than they paid — a “down round.” The bru­tal part is the tim­ing. These pro­vi­sions do noth­ing when every­thing is going well. They fire pre­cise­ly when you are weak­est — a bad econ­o­my, a missed quar­ter, a pan­dem­ic, a reg­u­la­to­ry change — and when they fire, they take more of your equi­ty to keep the investor whole at your expense.

There are two main forms:

  1. Weight­ed-aver­age anti-dilu­tion. The investor’s effec­tive price is adjust­ed using a for­mu­la that accounts for how much new mon­ey came in at the low­er price. This is the rea­son­able, stan­dard ver­sion. Accept it.
  2. Full-ratch­et anti-dilu­tion. The investor’s price resets all the way down to the new, low­er price as if they had invest­ed at that price orig­i­nal­ly — regard­less of how small the new round is. This is pun­ish­ing and trans­fers a large chunk of equi­ty to the exist­ing investor. Resist it.

The rea­son this mat­ters so much for SaaS founders is the opti­mism trap. Founders are vision­ary and pas­sion­ate; it does not occur to them that some­thing will go wrong, so they hap­pi­ly give away pro­tec­tions they assume will nev­er trig­ger. Investors know this, and they price it in. Assume things will go wrong at some point, because over a com­pa­ny’s life they almost always do, and nego­ti­ate these claus­es as if you will need them — because you might.

The Exit Waterfall and Order of Payouts — A descending series of carved stone basins arranged like a fountain

The Waterfall: How the Same Exit Pays Founders Differently

Investors and bankers talk about the water­fall — the spread­sheet that shows, when the com­pa­ny sells, who gets paid what and in what order. Mon­ey flows from the top of the water­fall (the most senior pref­er­ences) down to the bot­tom (com­mon share­hold­ers), and what­ev­er is left when it reach­es the bot­tom is what you and your team split. Know­ing your water­fall cold is the most impor­tant finan­cial lit­er­a­cy a founder can have, and the lack of it is what wipes founders out.

Let me show you why two founders with the same exit price can walk away with com­plete­ly dif­fer­ent amounts. Both com­pa­nies sell for $60M. Both founders start­ed own­ing 100% and raised the same $15M total. The only dif­fer­ence is the terms they signed.

Founder A raised $15M across rounds on sim­ple, non-par­tic­i­pat­ing 1x pref­er­ences, end­ing up own­ing 45% of the com­pa­ny on a ful­ly dilut­ed basis.

Founder B raised the same $15M but on par­tic­i­pat­ing 1x pref­er­ences with an 8% cumu­la­tive div­i­dend, accrued over an aver­age of four years, end­ing up with the same 45% own­er­ship on paper.

Founder A (clean terms)Founder B (loaded terms)
Exit price$60M$60M
Investor preference paid firstInvestors convert to common (better for them)$15M preference + ~$5.4M accrued dividends = $20.4M off the top
Remaining proceeds$60M shared by ownership$39.6M shared by ownership
Investors' participationNone — they took their 55%Investors also take 55% of the remaining $39.6M = $21.78M
Founder's take (45%)45% of $60M = $27M45% of $39.6M = $17.82M

Same com­pa­ny, same exit, same own­er­ship per­cent­age on the cap table — and a $9.18M dif­fer­ence in what the founder per­son­al­ly keeps. That gap is not cre­at­ed at exit. It was cre­at­ed years ear­li­er, on the term sheet, in claus­es the founder may not have ful­ly read. Now extend this to a com­pa­ny that raised $200M across many par­tic­i­pat­ing rounds with ratch­ets, and you can see how a real sale pro­duces a founder check of zero. The water­fall ran dry before it reached the bot­tom.

For more on how acquir­ers val­ue the under­ly­ing busi­ness that feeds this water­fall, see the guide on SaaS com­pa­ny val­u­a­tion and SaaS val­u­a­tion mul­ti­ples.

Control Terms: Who Actually Runs the Company

Eco­nom­ics decide what you keep. Con­trol terms decide whether you get to make the deci­sions — includ­ing the deci­sion to sell at a moment that is good for you.

Board Composition

The board of direc­tors gov­erns the com­pa­ny, hires and fires the CEO, and approves major deci­sions includ­ing a sale. The term sheet spec­i­fies how board seats are allo­cat­ed. A com­mon struc­ture when a sin­gle investor leads a round is that they take one board seat, some­times plus an observ­er seat (a non-vot­ing attendee, often used to sea­son their junior staff). The most com­mon ask is one seat plus a hand­ful of veto rights — not full con­trol.

The num­ber that mat­ters is the bal­ance. As long as founders and founder-friend­ly inde­pen­dents hold the major­i­ty of board seats, you con­trol your des­tiny. The moment investors hold a major­i­ty — or hold enough seats com­bined with pro­tec­tive pro­vi­sions to block you — you have hand­ed over the steer­ing wheel even if you still own most of the equi­ty. Watch the board math as close­ly as the cap table.

Protective Provisions (Veto Rights)

Pro­tec­tive pro­vi­sions are a list of actions the com­pa­ny can­not take with­out the pre­ferred investor’s con­sent. The most com­mon and most con­se­quen­tial is: you can­not sell the busi­ness with­out the investor’s approval. Read that again. Even if you own the major­i­ty of the com­pa­ny and an acquir­er offers a price you love, a sin­gle veto right can stop the sale — typ­i­cal­ly because the investor’s return tar­get has not been hit yet.

Oth­er com­mon pro­tec­tive pro­vi­sions cov­er rais­ing new debt, issu­ing new senior stock, chang­ing the size of the board, or amend­ing the char­ter. Some are rea­son­able guardrails. The sale-approval veto is the one that can trap you in your own com­pa­ny for years, so under­stand exact­ly what trig­gers it and nego­ti­ate carve-outs where you can — for exam­ple, an auto­mat­ic approval if the sale price exceeds a defined thresh­old that guar­an­tees the investor a strong return.

Founder Vesting

Most term sheets impose vest­ing on the founders’ own shares — mean­ing you earn your equi­ty back over time (often four years) even though you already own it. This feels insult­ing the first time you see it, but it serves a real pur­pose: it pro­tects the com­pa­ny and the oth­er founders if a co-founder walks away ear­ly. Nego­ti­ate for accel­er­a­tion pro­vi­sions — par­tic­u­lar­ly “dou­ble-trig­ger” accel­er­a­tion, where your unvest­ed shares vest imme­di­ate­ly if the com­pa­ny is acquired and you are ter­mi­nat­ed with­out cause. With­out it, an acquir­er can fire you the day after clos­ing and you for­feit the equi­ty you had not yet vest­ed.

This is not para­noia. Rough­ly half of founders are removed with­in one to two years of an acqui­si­tion. Plan for the pos­si­bil­i­ty that the buy­er does not want you long-term, and make sure your equi­ty is pro­tect­ed if that hap­pens. Equi­ty-man­age­ment plat­forms like Car­ta pub­lish data on stan­dard start­up financ­ing pro­vi­sions across thou­sands of rounds, which is worth review­ing to see what is gen­uine­ly mar­ket ver­sus what is being pushed onto you.

How to Actually Negotiate a Term Sheet

Know­ing the terms is half the bat­tle. Get­ting bet­ter ones is the oth­er half. A few moves that work:

  1. Run a com­pet­i­tive process before you sign any­thing. The sin­gle biggest source of lever­age is hav­ing more than one option. Investors and acquir­ers behave very dif­fer­ent­ly when they know you can walk to a com­peti­tor. This is also why the no-shop clause is so dan­ger­ous — it delib­er­ate­ly removes that lever­age.
  2. Ask for mul­ti­ple struc­tures, not yes/no. Rather than pre­sent­ing a sin­gle deal and forc­ing a bina­ry answer, go back with sev­er­al struc­tures you would be com­fort­able with — dif­fer­ent val­u­a­tions, pref­er­ence terms, or earn-out arrange­ments that all hit the oth­er side’s tar­get. It turns the con­ver­sa­tion from “no, I don’t like it” into mul­ti­ple choice, which is far more pro­duc­tive. The goal is a struc­ture that lets both sides hit their num­bers — a gen­uine win-win usu­al­ly exists if you look for it.
  3. Get a great attor­ney and, for larg­er deals, a banker. This is not the place to save mon­ey on advi­sors. A spe­cial­ist who nego­ti­ates these term sheets all day knows what is stan­dard, what is aggres­sive, and what to trade. Get­ting a clear, writ­ten list of the exact terms you want before you receive a term sheet is itself some­thing a good advi­sor helps with. Nev­er sign some­thing you do not ful­ly under­stand — get help under­stand­ing it first.
  4. Know your walk-away math. Build your own water­fall mod­el for each pro­posed term sheet. Know exact­ly what you take home at sev­er­al dif­fer­ent exit prices under each struc­ture. If you can­not mod­el it, you can­not nego­ti­ate it.

The whole point is to think like the per­son on the oth­er side of the table. They have mod­eled their return down to the basis point. Until you have mod­eled yours, you are nego­ti­at­ing blind.

When a Term Sheet Isn’t the Right Move At All

Before you opti­mize a term sheet, ask whether you should be rais­ing at all. The best way to grow a SaaS busi­ness is through oper­at­ing cash flow — mak­ing mon­ey from cus­tomers and rein­vest­ing it. That has been true for two thou­sand years and remains the most reli­able path. Out­side cap­i­tal should accel­er­ate a busi­ness that already works, nev­er paper over poor unit eco­nom­ics.

If your unit eco­nom­ics are not yet sound, fix those before you raise — review SaaS unit eco­nom­ics and your LTV/CAC ratio first, because no term sheet improves a busi­ness that los­es mon­ey on every cus­tomer. And if you do need cap­i­tal but want to keep more con­trol, debt can be an option for com­pa­nies with strong recur­ring rev­enue; see ven­ture debt and SaaS debt financ­ing for the trade-offs. For founders weigh­ing the broad­er deci­sion, ven­ture cap­i­tal vs boot­strap­ping lays out the full pic­ture, and SaaS exit strat­e­gy cov­ers where all of this is ulti­mate­ly head­ed.

The rea­son to under­stand term sheets is not to raise more mon­ey. It is to make sure that when cap­i­tal does come in, you keep enough of your com­pa­ny that the years of work are actu­al­ly worth it.

Frequently Asked Questions

Is a term sheet legally binding?

Most­ly no, but part­ly yes. The eco­nom­ic terms (val­u­a­tion, pref­er­ences) are gen­er­al­ly non-bind­ing until the long-form agree­ments are signed. How­ev­er, cer­tain claus­es — con­fi­den­tial­i­ty, the no-shop/ex­clu­siv­i­ty peri­od, and who pays expens­es — are usu­al­ly bind­ing the moment you sign. And in prac­tice, the eco­nom­ic terms rarely change after a signed term sheet, so treat all of it as if it were bind­ing.

What’s the most important term to negotiate?

The liq­ui­da­tion pref­er­ence, and specif­i­cal­ly whether it is sim­ple (non-par­tic­i­pat­ing) or par­tic­i­pat­ing. This sin­gle dis­tinc­tion can swing a founder’s exit pro­ceeds by mil­lions on the same sale price. Fight for sim­ple, non-par­tic­i­pat­ing, 1x pref­er­ences. Every­thing else is sec­ondary to get­ting this right.

What is a fair liquidation preference for a SaaS company?

A 1x non-par­tic­i­pat­ing pref­er­ence is the mar­ket stan­dard and the fair bench­mark. A 1x par­tic­i­pat­ing pref­er­ence is investor-favor­able but some­times accept­ed in com­pet­i­tive rounds — if so, push for a par­tic­i­pa­tion cap. Any­thing above 1x, or full-ratch­et anti-dilu­tion, is aggres­sive and should be resist­ed unless you have no alter­na­tives and under­stand exact­ly what you are giv­ing up.

Can I negotiate the valuation on a term sheet?

Yes, but it is often not where the real mon­ey is. A high­er val­u­a­tion with par­tic­i­pat­ing pref­er­ences, a cumu­la­tive div­i­dend, and full-ratch­et anti-dilu­tion can leave you worse off than a low­er val­u­a­tion with clean terms. Mod­el the water­fall under each struc­ture before decid­ing which val­u­a­tion is actu­al­ly “bet­ter.”

How long does a term sheet take to turn into a closed deal?

Typ­i­cal­ly 30 to 90 days from signed term sheet to closed deal, depend­ing on dili­gence and legal com­plex­i­ty. The no-shop peri­od is usu­al­ly set to rough­ly cov­er this win­dow, which is exact­ly why you want it as short as pos­si­ble — it lim­its how long you are locked out of your alter­na­tives.

Should I sign a term sheet without a lawyer?

No. The cost of a spe­cial­ist attor­ney is triv­ial com­pared to the life­time cost of a bad term. A good lawyer knows which terms are stan­dard, which are aggres­sive, and what to trade for what. For larg­er trans­ac­tions, add a banker. Nev­er sign a term you do not ful­ly under­stand — and if you do not under­stand a term, that is the sig­nal to get help, not to sign faster.

Facebooktwitterlinkedinmail
author avatar
Vic­tor Cheng
Author of Extreme Rev­enue Growth, Exec­u­tive coach, inde­pen­dent board mem­ber, and investor in SaaS com­pa­nies.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top